Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients

The aim of the retrospective study was to compare the immunophenotyping of T-lymphocytes, B-lymphocytes, and natural killer cells before the administration of the first and the second dose of ocrelizumab in 22 patients with multiple sclerosis in a three-year period (2019–2021) at the Department of N...

Descripción completa

Detalles Bibliográficos
Autores principales: Radmilo, Marija, Pavelin, Sanda, Vujović, Igor, Šoda, Joško, Rogić Vidaković, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953738/
https://www.ncbi.nlm.nih.gov/pubmed/36830890
http://dx.doi.org/10.3390/biomedicines11020353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953738/
https://www.ncbi.nlm.nih.gov/pubmed/36830890
http://dx.doi.org/10.3390/biomedicines11020353

Ejemplares similares